A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variants.
J Clin Invest
; 132(10)2022 05 16.
Article
in En
| MEDLINE
| ID: mdl-35316221
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
COVID-19 Vaccines
/
COVID-19
Type of study:
Clinical_trials
Limits:
Adolescent
/
Adult
/
Aged
/
Aged80
/
Humans
/
Middle aged
Language:
En
Journal:
J Clin Invest
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: